Recombinant proteins are produced using recombinant DNA technology, where the gene encoding a specific protein is inserted into a host organism's cells to produce the desired protein . Recombinant Klebsiella pneumoniae Zinc transport protein ZntB (zntB) refers to the protein ZntB, which is involved in zinc transport in Klebsiella pneumoniae, produced via recombinant DNA technology .
Recombinant proteins, including ZntB, have diverse applications across various fields .
Drug Discovery and Development Recombinant proteins are used to study the structure and function of target proteins involved in diseases, identify potential drug targets, screen potential drug candidates, and evaluate the efficacy and safety of therapeutic agents in preclinical animal models and clinical trials .
Diagnostics Recombinant proteins are used as antigens in immunoassays to detect specific antibodies in patient samples for diagnosing infectious diseases, autoimmune disorders, and allergies . They are also used as standards or controls to ensure the accuracy of test results in biochemical analysis techniques and vaccine production .
Molecular Biology Research Recombinant proteins facilitate expression studies, protein purification, functional studies, structural biology, drug development, vaccine production, diagnostic tools, and therapeutic proteins development .
Cell and Gene Therapy Research and Development Recombinant proteins stimulate cell growth and expansion, induce cell reprogramming, optimize viral vector production, purify therapeutic proteins, characterize cells, modulate the immune response, ensure quality control, facilitate in vivo imaging, and engineer therapeutic proteins with enhanced properties .
Klebsiella pneumoniae is a bacterium known to cause infections, particularly in individuals with weakened immune systems . Recent research has focused on understanding how classical Klebsiella pneumoniae transforms into hypervirulent strains, which can infect healthy individuals . Understanding the genetic elements responsible for hypervirulence is crucial for developing preventive therapies and control strategies .
Studies have identified several recombinant outer membrane proteins (KOMPs) of Klebsiella pneumoniae as potential vaccine candidates . These KOMPs, such as Kpn_Omp001, Kpn_Omp002, and Kpn_Omp005, have shown promise in inducing protective immune responses against K. pneumoniae infections in murine models . Immunization with these KOMPs resulted in reduced bacterial load in organs, indicating their protective efficacy . The protective effects are associated with KOMP-specific IgG, IgG1, and IgG2a, as well as IFN-γ-, IL4-, and IL17A-mediated immune responses .
The study of KOMPs revealed that humoral immunity may contribute to the protective effect of vaccination . Antiserum samples from mice immunized with KOMPs facilitated the killing of K. pneumoniae by HL-60 cells, suggesting the involvement of humoral immunity . Furthermore, these KOMPs elicited a significant increase in IFN-γ-, IL-4-, and IL-17A-secreting splenocytes, indicating that immunization induces strong antigen-specific Th1, Th2, and Th17 responses .
Mediates efflux of zinc ions.
KEGG: kpe:KPK_3033
ZntB is a funnel-shaped membrane protein composed of five identical subunits that together form a pore through the bacterial membrane. The full-length structure reveals a pentameric assembly with a total formula weight of approximately 183,260 Da . Each subunit contributes to forming the transport channel, with the intracellular domain creating a wide cytoplasmic funnel that narrows toward the membrane-spanning region. The protein contains distinct domains: a larger cytoplasmic domain and a smaller transmembrane domain that anchors the protein in the cell membrane .
ZntB plays a crucial role in zinc homeostasis in K. pneumoniae. While originally thought to function primarily as a zinc exporter similar to other bacterial species, recent research indicates that ZntB actually functions as a zinc importer driven by a proton gradient . This proton-driven zinc transport mechanism is particularly significant for K. pneumoniae pathogenicity, as zinc acquisition is essential during infection when the host environment typically restricts zinc availability through nutritional immunity . Zinc serves as a cofactor for approximately 6% of the bacterial proteome, making its acquisition vital for cellular functions .
K. pneumoniae employs multiple zinc transport systems, with ZntB functioning distinctly from the ATP-binding cassette (ABC) transporters such as ZnuCBA and ZniCBA . While ZnuCBA and ZniCBA utilize ATP hydrolysis to power zinc uptake, ZntB belongs to the CorA metal ion transporter (MIT) family and uses a proton gradient for energizing transport . Additionally, ZntB forms a homopentameric complex, unlike the heteromeric assembly of ABC transporters. These systems likely function under different physiological conditions, with ZntB possibly serving under specific pH or zinc concentration environments that favor its proton-coupled transport mechanism .
Two primary conformational states have been identified through structural studies of ZntB: a zinc-free state and a zinc-bound state. The full-length structure of E. coli ZntB (which shares high homology with K. pneumoniae ZntB) reveals the zinc-free state, while the soluble domain structure of Salmonella typhimurium ZntB represents a zinc-bound state . Comparison between these structures reveals dramatic differences in surface electrostatic potentials and internal pore shape . Unlike the related CorA Mg²⁺ channel, ZntB does not collapse into a highly asymmetrical state upon depletion of divalent cations, suggesting a distinct transport mechanism . The conformational transitions likely involve helical rotations, particularly of transmembrane helix TM1, which contains conserved basic and acidic residues that may facilitate the charge inversion observed between conformational states .
Electrostatic properties are critical for ZntB function. Surface potential calculations reveal significant differences between zinc-free and zinc-bound states . The cytoplasmic domain of full-length zinc-free ZntB exhibits a strong positive electrostatic surface potential, whereas the potential in the zinc-bound state is predominantly negative . This charge inversion between symmetrical states likely facilitates zinc transport through the channel. Additionally, the ZntB structure contains chloride ion binding sites that neutralize positively-charged amino acids, tuning the funnel's properties to favor passage of divalent zinc ions rather than monovalent ions like sodium or potassium . Two rings of acidic amino acids at the base of the funnel may also participate in stripping water molecules from zinc ions before transport .
The pentameric assembly of ZntB creates a symmetrical pore structure that is essential for its transport function. Each of the five subunits contributes specific residues to form the ion conduction pathway . This pentameric arrangement creates two key functional features: a cytoplasmic funnel that selects for zinc ions through electrostatic interactions, and a narrower transmembrane pore that facilitates controlled ion transport . The symmetrical arrangement allows for coordinated conformational changes during transport cycles, with the five subunits working in concert to regulate zinc passage . This pentameric architecture distinguishes ZntB from many other transport proteins and is shared with other members of the CorA metal ion transporter family, though the transport mechanisms differ considerably .
For structural studies of recombinant K. pneumoniae ZntB, a systematic approach incorporating several key methodologies is recommended. Based on successful protocols used for E. coli ZntB, researchers should:
Design expression constructs with a C-terminal purification tag (such as His6 or His8) to minimize interference with the functional N-terminal domain.
Express the protein in E. coli BL21(DE3) or similar strains under control of a T7 promoter.
Induce expression at lower temperatures (16-18°C) to enhance proper folding of this membrane protein.
Extract the protein using mild detergents such as n-dodecyl-β-D-maltopyranoside (DDM) or lauryl maltose neopentyl glycol (LMNG) that maintain the native pentameric structure.
Purify using immobilized metal affinity chromatography followed by size exclusion chromatography to isolate the pentameric assembly.
Assess protein quality using SDS-PAGE, native PAGE, and thermal stability assays.
For cryo-EM studies specifically, a final concentration of approximately 10 mg/ml is recommended, with application to glow-discharged holey carbon grids .
Several complementary techniques have proven effective for characterizing zinc binding and transport by ZntB:
| Technique | Application | Advantages | Limitations |
|---|---|---|---|
| Isothermal Titration Calorimetry (ITC) | Direct measurement of binding thermodynamics | Provides binding constants, stoichiometry, and thermodynamic parameters | Requires significant amounts of purified protein |
| Radiolabeled (⁶⁵Zn) uptake assays | Direct measurement of transport in liposomes | Quantitatively measures actual zinc transport | Requires radioactive materials and specialized facilities |
| Fluorescent transport assays | Indirect measurement of transport activity | Non-radioactive alternative, good for kinetic studies | May be affected by background fluorescence |
| Zinc-sensitive fluorescent dyes | Monitoring intracellular zinc levels | Can be used in live cell systems | Potential for interference from other metal ions |
For the most robust characterization, researchers should employ multiple approaches, particularly combining the direct biophysical measurement of zinc binding (ITC) with functional transport assays using ZntB reconstituted into liposomes .
To effectively study ZntB conformational changes, researchers should employ a multi-technique approach:
Cryo-electron microscopy (cryo-EM) has been successfully used to determine the full-length structure of ZntB at 4.2 Å resolution, capturing specific conformational states .
Site-directed spin labeling combined with electron paramagnetic resonance (EPR) spectroscopy can monitor distances between specific residues during conformational changes.
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) can identify regions of the protein that undergo structural rearrangements upon zinc binding.
Single-molecule Förster resonance energy transfer (smFRET) can detect distance changes between labeled domains during the transport cycle.
Molecular dynamics simulations based on experimental structures can provide insights into the dynamic processes not captured in static structures.
Functional studies with site-directed mutations at key positions can validate the importance of specific residues in the conformational transition.
The comparison between zinc-free and zinc-bound structures has already revealed significant conformational differences and electrostatic surface potential changes that likely represent different stages in the transport cycle .
K. pneumoniae employs multiple systems for zinc homeostasis, with ZntB functioning alongside the ATP-binding cassette (ABC) transporters ZnuCBA and ZniCBA . These systems likely operate under different conditions or in response to different signals:
ZnuCBA and ZniCBA are high-affinity ATP-dependent zinc importers that function redundantly, with either system sufficient for wild-type growth and zinc acquisition under standard laboratory conditions .
ZntB provides a proton gradient-driven mechanism for zinc import that may be particularly important under specific environmental conditions, such as acidic microenvironments where the proton gradient is stronger .
The expression of these zinc transport systems is likely regulated by zinc-responsive transcription factors, coordinating their activity based on environmental zinc availability.
The expression and function of ZntB in K. pneumoniae are likely modulated by several environmental factors, particularly those relevant to infection contexts:
Understanding how these environmental variables affect ZntB expression and function is crucial for comprehending the role of this transporter in K. pneumoniae physiology and pathogenicity under various infection scenarios.
Designing effective inhibitors against K. pneumoniae ZntB requires a structure-guided approach based on the available structural and functional information:
Target identification: Several key features of ZntB represent potential targets for inhibition:
The zinc binding site
The proton coupling mechanism
The conformational transition pathway
Subunit interfaces in the pentameric assembly
Rational design strategies:
Structure-based virtual screening using the available ZntB structures to identify compounds that may bind to crucial functional regions
Fragment-based drug discovery focusing on the unique features of the zinc transport pathway
Design of transition-state analogs that could lock the protein in non-functional conformations
Key considerations:
Specificity for bacterial ZntB over human zinc transporters to minimize toxicity
Penetration of the bacterial outer membrane, particularly challenging in Gram-negative K. pneumoniae
Resistance development potential, which may be mitigated by targeting highly conserved and functionally essential regions
Validation approaches:
In vitro zinc transport assays with purified protein reconstituted in liposomes
Bacterial growth assays under zinc-limited conditions
Infection models to evaluate efficacy in physiologically relevant contexts
Given that K. pneumoniae is a World Health Organization priority pathogen with increasing antimicrobial resistance , ZntB represents a novel target for therapeutic development that could complement existing treatment strategies.
Studying ZntB in K. pneumoniae biofilms requires specialized approaches that address the unique properties of the biofilm environment:
These approaches would provide insight into how K. pneumoniae modulates zinc homeostasis in the complex and heterogeneous biofilm environment, which is particularly relevant for chronic infections and antimicrobial resistance.
To effectively analyze ZntB sequence variations across clinical K. pneumoniae isolates, researchers should employ a comprehensive bioinformatic and functional validation approach:
Sequence acquisition and analysis:
Whole genome sequencing of diverse clinical isolates
PCR amplification and sequencing of the zntB gene from isolates
Database mining of existing K. pneumoniae genomes for zntB sequences
Bioinformatic analysis pipeline:
Multiple sequence alignment to identify conserved and variable regions
Phylogenetic analysis to correlate ZntB variants with strain lineages
Structural mapping of variations onto the 3D structure of ZntB
Prediction of functional impact using computational tools
Correlation with clinical data:
Association analysis between ZntB variants and infection sites
Correlation with antimicrobial resistance profiles
Relationship to virulence factor expression and clinical outcomes
Functional validation:
Heterologous expression of variant ZntB proteins
Zinc transport assays to assess functional differences
Competition assays between strains with different ZntB variants
Site-directed mutagenesis to confirm the importance of specific variations
Evolutionary analysis:
Assessment of selection pressure on different ZntB domains
Identification of recombination events
Comparison with ZntB evolution in other bacterial species
This comprehensive approach would provide insights into how ZntB variation might contribute to K. pneumoniae adaptation to different host environments and potentially influence virulence or antimicrobial resistance profiles.
Several promising research directions could enhance our understanding of ZntB regulation in K. pneumoniae:
Transcriptional regulation:
Identification of zinc-responsive transcriptional regulators controlling zntB expression
Characterization of the zntB promoter and regulatory elements
Investigation of cross-talk with other metal-responsive regulatory pathways
Post-transcriptional and post-translational regulation:
Role of small RNAs in modulating zntB expression
Identification of potential protein modifications affecting ZntB activity
Protein-protein interactions influencing ZntB localization or function
Environmental sensing mechanisms:
How zinc levels are sensed and integrated with ZntB expression
Role of proton gradient sensing in ZntB regulation
Integration with bacterial stress response systems
Systems biology approaches:
Network analysis of zinc homeostasis in K. pneumoniae
Mathematical modeling of zinc transport dynamics
Integration of transcriptomic, proteomic, and metabolomic data
Infection-relevant regulation:
ZntB regulation during different stages of infection
Host factors influencing ZntB expression
Regulatory changes in antimicrobial resistant isolates
These research directions would provide a comprehensive understanding of how K. pneumoniae regulates ZntB expression and activity to maintain zinc homeostasis under various environmental conditions, potentially revealing new therapeutic targets.
Advanced structural biology techniques could significantly enhance our understanding of the ZntB transport mechanism:
Time-resolved cryo-EM:
Capturing transient intermediates in the transport cycle
Visualization of conformational changes during zinc binding and transport
Construction of molecular movies depicting the transport process
Single-particle cryo-EM with improved resolution:
Higher resolution structures below 3 Å to visualize water molecules and precise ion positions
Identification of specific zinc binding sites within the transport pathway
Detailed view of the proton coupling mechanism
Cryo-electron tomography:
Visualization of ZntB in its native membrane environment
Understanding of membrane organization and potential clustering
Integrative structural biology approaches:
Combining cryo-EM with mass spectrometry, spectroscopy, and computational methods
Cross-linking mass spectrometry to identify dynamic protein interfaces
Molecular dynamics simulations based on high-resolution structures
In situ structural studies:
Cellular cryo-electron tomography to visualize ZntB in bacterial cells
Correlative light and electron microscopy to link structure with function
These advanced approaches would help resolve remaining questions about the precise mechanism of proton-coupled zinc transport, the nature of the conformational changes during the transport cycle, and how the pentameric assembly coordinates these changes for efficient transport.
To effectively study the interplay between ZntB and host nutritional immunity during K. pneumoniae infection, researchers should consider these experimental approaches:
In vivo infection models:
Mouse models of pneumonia, urinary tract infection, or systemic infection
Tissue-specific zinc measurements during infection progression
Comparison of wild-type and zntB mutant K. pneumoniae virulence
Ex vivo analyses:
Transcriptional profiling of K. pneumoniae recovered from infection sites
Measurement of zntB expression in bacteria isolated from different host tissues
Assessment of zinc content in bacteria recovered from host environments
Host response studies:
Analysis of host zinc transporter expression during infection
Characterization of zinc-binding antimicrobial proteins (calprotectin, S100 proteins)
Neutrophil extracellular trap (NET) formation and zinc sequestration
Advanced imaging techniques:
Intravital microscopy with fluorescent zinc probes
Immunofluorescence microscopy for co-localization of bacteria with host zinc-binding proteins
X-ray fluorescence microscopy for elemental analysis at infection sites
Genetic approaches:
Construction of K. pneumoniae strains with regulated zntB expression
Host models with modified zinc homeostasis (transporter knockouts)
Dual RNA-seq to simultaneously profile host and pathogen transcriptional responses
These approaches would provide insights into how K. pneumoniae ZntB functions to overcome host-imposed zinc limitation, potentially revealing new therapeutic strategies targeting this host-pathogen interface.